This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, University of Cambridge. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2017
Title: The Innovations of Raphaël Joël Rodriguez
Introduction
Raphaël Joël Rodriguez is an accomplished inventor based in Vers-Pont-du-Gard, France. He has made significant contributions to the field of medical research, particularly in the treatment of disorders related to laminopathies, aging, and cancer. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Rodriguez holds a patent for NAT10 modulators for treating or preventing laminopathies, aging, and cancer. This invention relates to compounds that can treat or prevent disorders associated with Lamin A and/or Lamin C depletion or LMNA mutations. These disorders include laminopathy, premature aging disorders, normal aging, and certain types of cancer characterized by low levels of LMNA expression. His work in this area represents a significant advancement in therapeutic options for patients suffering from these conditions.
Career Highlights
Throughout his career, Raphaël Joël Rodriguez has worked with notable organizations, including Cambridge Enterprise Limited and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Rodriguez has collaborated with several esteemed colleagues, including Delphine Laurence, Daniele Larrieu, and Sébastien Frédéric Stéphane Britton. These partnerships have enhanced his research and expanded the impact of his inventions.
Conclusion
Raphaël Joël Rodriguez is a pioneering inventor whose work in the field of laminopathies, aging, and cancer has the potential to transform medical treatments. His innovative patent and collaborations with esteemed colleagues highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile